Viewing Study NCT00498992


Ignite Creation Date: 2025-12-24 @ 3:48 PM
Ignite Modification Date: 2026-01-20 @ 6:19 PM
Study NCT ID: NCT00498992
Status: UNKNOWN
Last Update Posted: 2013-09-20
First Post: 2007-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Regenecare® Wound Gel in Treating Rash in Patients Receiving Cetuximab or Other Epidermal Growth Factor Receptor Inhibitor Therapy for Cancer
Sponsor: Ingalls Memorial Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dermatologic Complications View
None Unspecified Adult Solid Tumor, Protocol Specific View
Keywords:

Keywords

Keyword Brief Keyword Text View
None dermatologic complications View
None unspecified adult solid tumor, protocol specific View